Abstract:Cardiovascular diseases and cancer represent the two greatest threats to human health, and the correlation between them has garnered increasing attention. N-terminal pro-brain natriuretic peptide (NT-proBNP), as a biomarker of cardiac dysfunction, plays an important role in assessing patients′ cardiac function and the prognosis of cardiovascular diseases. Additionally, NT-proBNP has shown potential value in monitoring cardiotoxicity caused by tumor treatment, evaluating the prognosis of cancer patients, aiding tumor diagnosis. Moreover, tumors affect the synthesis of NT-proBNP. In this article, we reviewed the correlation between NT-proBNP and tumors, aiming to enhance the understanding of potential application of NT-proBNP in oncology.